Mackenzie Financial
INDV icon

Mackenzie Financial’s Indivior Pharmaceuticals INDV Stock Holding History

Mackenzie Financial’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,456
Closed -$252K – 1744
2025
Q3 		$252K Buy
+10,456
New +$219K ﹤0.01% 1472
2024
Q3 		– Sell
-497,555
Closed -$7.8M – 1632
2024
Q2 		$7.8M Sell
497,555
-57,185
-10% -$1.03M 0.01% 474
2024
Q1 		$11.9M Buy
554,740
+4,100
+0.7% +$77K 0.02% 413
2023
Q4 		$8.31M Sell
550,640
-11,955
-2% -$212K 0.01% 462
2023
Q3 		$11.3M Buy
562,595
+1,909
+0.3% +$43.5K 0.02% 409
2023
Q2 		$12.8M Buy
+560,686
New +$12.9M 0.02% 407

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mackenzie Financial's INDV Position: Q4 2025 in Review

Mackenzie Financial sold out of Indivior Pharmaceuticals (INDV) in Q4 2025, closing a stake of 10,456 shares — an estimated $252K sold.

Mackenzie Financial first reported a position in INDV in Q2 2023 and held it in 6 quarters. The position peaked at $12.8M in Q2 2023. 259 funds tracked by Wall St. Rank hold INDV as of Q4 2025.

  • Mackenzie Financial reported no remaining Indivior Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Mackenzie Financial sold 10,456 Indivior Pharmaceuticals shares in Q4 2025, an estimated $252K.
  • Mackenzie Financial first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Mackenzie Financial's Indivior Pharmaceuticals position peaked at $12.8M in Q2 2023.
  • 259 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.